Category · 9 articles
Metabolic
Research-use-only roundups categorized under Metabolic.
AOD-9604: Research Roundup
An hGH fragment analog with lipolytic research interest. What preclinical literature reports — and where the evidence gaps are.
Cagrilintide: Research Roundup
A long-acting amylin analog studied alongside GLP-1 agonists in metabolic research. Mechanism, literature, and quality considerations.
Exenatide: Research Roundup
The first-in-class GLP-1 receptor agonist derived from exendin-4. Foundational incretin literature, mechanisms, and material-quality considerations.
Liraglutide: Research Roundup
An acylated GLP-1 receptor agonist with extensive published trial literature. What mechanisms and evidence tiers mean for research-grade material.
Mazdutide: Research Roundup
A dual GLP-1 and glucagon receptor agonist in active clinical development. What published phase 2 literature reports within an RUO frame.
Retatrutide: Research Roundup
A triple GLP-1/GIP/glucagon receptor agonist in early clinical research. Preclinical context, evidence gaps, and material evaluation.
Semaglutide: Research Roundup
A GLP-1 receptor agonist with extensive published literature. What preclinical and clinical research reports — within an RUO frame.
Survodutide: Research Roundup
A dual GLP-1/glucagon receptor agonist studied in metabolic and MASH research trials. Phase 2 literature and RUO material considerations.
Tirzepatide: Research Roundup
A dual GIP/GLP-1 receptor agonist studied in metabolic research. Mechanism context, published evidence, and documentation expectations.